influenza, there are inactivated alternatives that can be safely given to RMD patients taking immunosuppressive medication. Conventional DMARDs. Two observational studies in patients with RMDs who were only taking conventional DMARDs and/or prednisone <20 mg daily at the time they received the yellow fever vaccine observed no cases of infection 68 Biologic DMARDs. In a large RCT of RMD patients taking TNFi who were given the live attenuated VZV vaccine, there were no confirmed cases of